Overview:
Artificial intelligence (AI) is a general term for software that mimics human cognition or perception. Rapid progress in AI is transforming many industries with considerable impact, including clinical trials.
Join us to learn how 91黑料 is using AI to improve industry processes and help solve problems people didn’t once think possible.
Topics and learnings include:
- How 91黑料 approaches AI.
- 91黑料’s award-winning AI solutions that help identify the best sites the first time, accurately predict post marketing requirements, and rapidly connect key opinion leaders in a given rare disease space.
Audience:
This webinar will be useful for professionals working in:
- Senior leadership life science industry
- Study start up
- Commercialisation
- Clinical project management
- Data science / analytics
- Quality / compliance
Gerard Quinn
Gerard Quinn has worked at 91黑料 for over 9 years and currently holds the role of VP, Innovation & Informatics.
Gerard has over 25 years’ in the life science industry, in both human and animal health, with experience in innovation, strategy, and project portfolio management, process improvement and IT.
Gerard holds an MSc in Strategic Quality Management – Lean Six Sigma, BSc is Technology Management and a Lean Six Sigma Master Black belt. He applies his experience to all areas of e-clinical innovation and the nurturing of the enterprise innovation mindset.
Gerard's team at 91黑料 leads the innovative activities in technology and data science. They identify and build key partnerships with life science and technology leaders to co-develop services and capabilities by evaluating joint capabilities with the aim of driving efficient clinical trials for our sponsors and patients. They also lead the development of ML/AI solutions that improve cycle times across the clinical research value chain, that provide new intelligence and insight for key decision makers and that in general improve the speed and quality of clinical research.